Laura Ioana Popa

Ms. Laura Ioana Popa

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Gratiela GRADISTEANU PircalabioruGratiela GRADISTEANU Pircalabioru
Gratiela GRADISTEANU Pircalabioru
LPLaura Ioana Popa
Laura Ioana Popa
Luminita MarutescuLuminita Marutescu
Luminita Marutescu
IGIrina Gheorghe
Irina Gheorghe
MPMarcela Popa
Marcela Popa
Carmen ChifiriucCarmen Chifiriuc
Carmen Chifiriuc
Decades of antibiotic misuse in clinical settings, animal feed, and within the food industry have led to a concerning rise in antibiotic-resistant bacteria. Every year, antimicrobial-resistant infections cause 700,000 deaths, with 10 million casualties expected by 2050, if this trend continues. Hence, innovative solutions are imperative to curb antibiotic resistance. Bacteria produce a potent arsenal of drugs with remarkable diversity that are all distinct from those of current antibiotics. Bacteriocins are potent small antimicrobial peptides synthetized by certain bacteria that may be appointed as alternatives to traditional antibiotics. These molecules are strategically employed by commensals, mostly Firmicutes, to colonize and persist in the human gut. Bacteriocins form channels in the target cell membrane, leading to leakage of low-molecular-weight, causing the disruption of the proton motive force. The objective of this review was to list and discuss the potential of bacteriocins as antimicrobial therapeutics for infections produced mainly by resistant pathogens.

2 February 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MPMădălina Preda
Mădălina Preda
Mara MihaiMara Mihai
Mara Mihai
LPLaura Ioana Popa
Laura Ioana Popa
LDLia-Mara Dițu
Lia-Mara Dițu
AHAlina Maria Holban
Alina Maria Holban
Mircea Ioan PopaMircea Ioan Popa
Mircea Ioan Popa
Chronic infections represent an important burden on the healthcare system and have a significant impact on the patients’ quality of life. While Staphylococcus spp. are commensal bacteria, they can become pathogenic, leading to various types of infections. In this study we aimed to characterize the virulence profiles of staphylococcal strains involved in difficult-to-treat skin and soft tissue infections, from both phenotypic and genotypic points of view. Phenotypic ability of the strains to secrete soluble virulence factors was assessed by a culturing dependent assay and their capacity to develop biofilms on inert substrate was screened by an adapted crystal violet microtiter method. We also tested the presence of several virulence genes by PCR. Most of the studied strains were isolated from purulent secretions of acne lesions and frequently secreted two or three soluble virulence factors. Most frequently secreted soluble virulence factors were caseinase (89%), lipase (71%) and lecithinase (67%). Almost half of the strains produced a well-represented biofilm. The molecular characterization showed the presence of the genes cna, hlg, clfA, and clfB. Staphylococcal strains that produce difficult-to-treat skin and soft tissue infections seem to be characterized by an enhanced ability to produce different soluble virulence factors and to develop biofilms in vitro. Further studies need to be developed in other Staphylococcus spp. infections in order to confirm this hypothesis.

7 December 2021 in Briefings in Bioinformatics
Verified
Journal Article
Open access
PDF file
NSNicoleta Siminea
Nicoleta Siminea
VPVictor Popescu
Victor Popescu
JMJose Angel Sanchez Martin
Jose Angel Sanchez Martin
DFDaniela Florea
Daniela Florea
GGGeorgiana Gavril
Georgiana Gavril
IPIon Petre
Ion Petre
To better understand the potential of drug repurposing in COVID-19, we analyzed control strategies over essential host factors for SARS-CoV-2 infection. We constructed comprehensive directed protein–protein interaction (PPI) networks integrating the top-ranked host factors, the drug target proteins and directed PPI data. We analyzed the networks to identify drug targets and combinations thereof that offer efficient control over the host factors. We validated our findings against clinical studies data and bioinformatics studies. Our method offers a new insight into the molecular details of the disease and into potentially new therapy targets for it. Our approach for drug repurposing is significant beyond COVID-19 and may be applied also to other diseases.

24 June 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
IGIrina Gheorghe
Irina Gheorghe
IBIlda Czobor Barbu
Ilda Czobor Barbu
MSMarius Surleac
Marius Surleac
IAIonela Avram
Ionela Avram
LPLaura Ioana Popa
Laura Ioana Popa
ZZZhiyong Zong
Zhiyong Zong
Acinetobacter baumannii has emerged worldwide as a dominant pathogen in a broad range of severe infections, raising an acute need for efficient antibacterials. This is the first report on the resistome and virulome of 33 extended drug-resistant and carbapenem-resistant A. baumannii (XDR CRAB) strains isolated from hospitalized and ambulatory patients in Bucharest, Romania. A total of 33 isolates were collected and analyzed using phenotypic antibiotic susceptibility and conjugation assays, PCR, whole-genome sequencing (WGS), pulsed-field gel electrophoresis (PFGE) and MultiLocus Sequence Typing (MLST). All isolates were extensively drug-resistant (XDR), being susceptible only to colistin. The carbapenem resistance was attributed by PCR mainly to blaOXA-24 and blaOXA-23 genes. PFGE followed by MLST analysis demonstrated the presence of nine pulsotypes and six sequence types. WGS of seven XDR CRAB isolates from healthcare-associated infections demonstrated the high diversity of resistance genes repertoire, as well as of mobile genetic elements, carrying ARGs for aminoglycosides, sulphonamides and macrolides. Our data will facilitate the understanding of resistance, virulence and transmission features of XDR AB isolates from Romanian patients and might be able to contribute to the implementation of appropriate infection control measures and to develop new molecules with innovative mechanisms of action, able to fight effectively against these bugs, for limiting the spread and decreasing the infection rate and mortality.

14 September 2022 in Antimicrobial Resistance & Infection Control
Verified
Journal Article
Open access
PDF file
IGIrina Gheorghe
Irina Gheorghe
IBIlda Czobor Barbu
Ilda Czobor Barbu
LPLaura Ioana Popa
Laura Ioana Popa
Gratiela GRADISTEANU PircalabioruGratiela GRADISTEANU Pircalabioru
Gratiela GRADISTEANU Pircalabioru
MPMarcela Popa
Marcela Popa
Carmen ChifiriucCarmen Chifiriuc
Carmen Chifiriuc
Background: Romania is one of the European countries reporting very high antimicrobial resistance (AMR) rates and consumption of antimicrobials. We aimed to characterize the AMR profiles and clonality of 304 multi-drug resistant (MDR) Acinetobacter baumannii (Ab) and Pseudomonas aeruginosa (Pa) strains isolated during two consecutive years (2018 and 2019) from hospital settings, hospital collecting sewage tanks and the receiving wastewater treatment plants (WWTPs) located in the main geographical regions of Romania. Methods: The strains were isolated on chromogenic media and identified by MALDI-TOF-MS. Antibiotic susceptibility testing and confirmation of ESBL- and CP- producing phenotypes and genotypes were performed. The genetic characterization also included horizontal gene transfer experiments, whole-genome sequencing (WGS), assembling, annotation and characterization. Results: Both clinical and aquatic isolates exhibited high MDR rates, especially the Ab strains isolated from nosocomial infections and hospital effluents. The phenotypic resistance profiles and MDR rates have largely varied by sampling point and geographic location. The highest MDR rates in the aquatic isolates were recorded in Galați WWTP, followed by Bucharest. The Ab strains harbored mostly blaOXA-23, blaOXA-24, blaSHV, blaTEM and blaGES, while Pa strains blaIMP, blaVIM, blaNDM, blaVEB, blaGES and blaTEM, with high variations depending on the geographical zone and the sampling point. The WGS analysis revealed the presence of antibiotic resistance genes (ARGs) to other antibiotic classes, such as aminoglycosides, tetracyclines, sulphonamides, fosfomycin, phenicols, trimethoprim-sulfamethoxazole as well as class 1 integrons. The molecular analyses highlighted: (i) The presence of epidemic clones such as ST2 for Ab and ST233 and ST357 for Pa; (ii) The relatedness between clinical and hospital wastewater strains and (iii) The possible dissemination of clinical Ab belonging to ST2 (also proved in the conjugation assays for blaOXA-23 or blaOXA-72 genes), ST79 and ST492 and of Pa strains belonging to ST357, ST640 and ST621 in the wastewaters. Conclusion: Our study reveals the presence of CP-producing Ab and Pa in all sampling points and the clonal dissemination of clinical Ab ST2 strains in the wastewaters. The prevalent clones were correlated with the presence of class 1 integrons, suggesting that these isolates could be a significant reservoir of ARGs, being able to persist in the environment.

8 September 2016 in bioRxiv
Verified
Preprint
Open access
PDF file
LPLaura Ioana Popa
Laura Ioana Popa
ARAttila Ratiu
Attila Ratiu
AEAlexandru Ecovoiu
Alexandru Ecovoiu
Insertional mutagenesis experiments performed on Drosophila melanogaster model often relies on induced mobilization of artificial transposons derived from P mobile element. In an attempt to detect transposition preferences, we accomplished a pilot study concerning the insertional patterns of P{lacW} and P{EP} constructs in the third chromosome of D. melanogaster. Our inventory inquiry considered 2177 insertions of P{lacW} and 1646 insertions of P{EP} available in FB2016_02 release of FlyBase and revealed insertional hotspots and coldspots in 3L and 3R, but also a preference of both artificial transposons to insert in 3R. The general distribution of P{lacW} and P{EP} insertions appears to be similar but not identical, probably due to differences in size and molecular architecture of these transposons. Our results may have predictive value for experimental design of insertional mutagenesis screenings, but are also expected to contribute to a better understanding of P transposon biology.